508 related articles for article (PubMed ID: 17182569)
1. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.
Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A
J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569
[TBL] [Abstract][Full Text] [Related]
2. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
3. The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells.
Kreijveld E; Koenen HJ; Hilbrands LB; van Hooff HJ; Joosten I
Blood; 2007 Jan; 109(1):244-52. PubMed ID: 16902146
[TBL] [Abstract][Full Text] [Related]
4. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
[TBL] [Abstract][Full Text] [Related]
5. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
6. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
Stroopinsky D; Avivi I; Rowe JM; Avigan D; Katz T
Eur J Immunol; 2009 Oct; 39(10):2703-15. PubMed ID: 19634189
[TBL] [Abstract][Full Text] [Related]
9. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
[TBL] [Abstract][Full Text] [Related]
10. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
Allan SE; Crome SQ; Crellin NK; Passerini L; Steiner TS; Bacchetta R; Roncarolo MG; Levings MK
Int Immunol; 2007 Apr; 19(4):345-54. PubMed ID: 17329235
[TBL] [Abstract][Full Text] [Related]
11. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans.
Cavassani KA; Campanelli AP; Moreira AP; Vancim JO; Vitali LH; Mamede RC; Martinez R; Silva JS
J Immunol; 2006 Nov; 177(9):5811-8. PubMed ID: 17056505
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
14. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
15. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
[TBL] [Abstract][Full Text] [Related]
16. Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene.
Guillot-Delost M; Cheraï M; Hamel Y; Rosenzwajg M; Baillou C; Simonin G; Leclercq V; Mariotti-Ferrandiz ME; Six A; Bon-Durand V; Maury S; Salomon BL; Cohen JL; Klatzmann D; Lemoine FM
J Gene Med; 2008 Aug; 10(8):834-46. PubMed ID: 18615770
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.
Ji J; Cloyd MW
Int Immunol; 2009 Mar; 21(3):283-94. PubMed ID: 19208751
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
19. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.
Li R; Perez N; Karumuthil-Melethil S; Prabhakar BS; Holterman MJ; Vasu C
J Immunol; 2007 Oct; 179(8):5191-203. PubMed ID: 17911604
[TBL] [Abstract][Full Text] [Related]
20. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
